Orserdu (elacestrant) - Menarini
Kisqali (ribociclib) - Novartis
Ibrance (palbociclib) - Pfizer
Inluriyo (imlunestrant) - Eli Lilly
Verzenio (abemaciclib) - Eli Lilly
Etcamah (camizestrant) - AstraZeneca
Camizestrant (Etcamah) for advanced breast cancer. (PubMed, Med Lett Drugs Ther) - Oct 19, 2026 - No abstract available 
Journal • Breast Cancer • Oncology • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42891994
 
Oct 19, 2026
 
Prev Next